5
total announcements
SHUKRAPHAR.NS · 15 min delayed
Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Limited has informed the Exchange about General Updates regarding media coverage of its NSE listing and strategic direction.
Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Limited has informed the Exchange about General Updates, including approval of proposal for change of name and expansion of main objects to include medical technology.
Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Limited has informed the Exchange about General Updates
Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Limited has informed the Exchange about General Updates, specifically the commencement of trading of its equity shares on the National Stock Exchange of India Limited (NSE) with effect from August 14, 2026.
Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Limited has announced its direct listing on the National Stock Exchange (NSE) and will commence trading on August 14, 2026. The company will continue to trade on the Bombay Stock Exchange (BSE) as well. The listing is aimed at expanding the company's visibility, attracting a broader base of institutional and retail investors, and deepening market liquidity.